Stephen J. Luen

595 citations
7 papers · 143 indexed · h-index 3
Topics
PARP inhibition in cancer therapy (3 papers)Advanced Breast Cancer Therapies (2 papers)Cancer Immunotherapy and Biomarkers (2 papers)

In The Last Decade

Stephen J. Luen

6 papers receiving 140 citations

Peers

Stephen J. Luen
Comparison fields: 5 of 41
  • Oncology 108
  • Molecular Biology 61
  • Immunology 43
  • Pulmonary and Respiratory Medicine 22
  • Cancer Research 21
Replace Francisca Reyes Turcu with:
Francisca Reyes Turcu United States
Georgia Spain United Kingdom
Nicole Fairweather Australia
Pierre Foidart Belgium
Omar Saavedra Spain
Simon P. Watkins United States
Carlos R. Garcia-Batres Canada
Paul A. Ellis United States
Elizabeth Lieschke Australia
Syed O. Ali United Kingdom
Stephen J. Luen relative to Francisca Reyes Turcu United States Francisca Reyes Turcu's profile →
Citations per field
00.5×1.5×1.9×
Francisca Reyes Turcu · 1×
Citations per year

Countries citing papers authored by Stephen J. Luen

Since Specialization
Citations

This map shows the geographic impact of Stephen J. Luen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen J. Luen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen J. Luen more than expected).

Fields of papers citing papers by Stephen J. Luen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen J. Luen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen J. Luen. The network helps show where Stephen J. Luen may publish in the future.

Co-authorship network of co-authors of Stephen J. Luen

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen J. Luen. A scholar is included among the top collaborators of Stephen J. Luen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen J. Luen. Stephen J. Luen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 2
5 4
6 52
7 83

About Stephen J. Luen

Stephen J. Luen is a scholar working on Physiology, Oncology and Immunology, having authored 7 papers that have together received 143 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (3 papers), Advanced Breast Cancer Therapies (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Oncology (108 citations), Immunology (43 citations) and Cancer Research (21 citations). Stephen J. Luen has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Sherene Loi, Roberto Salgado, Peter Savas, Lironne Wein, Adam Sharp, Alison M. Schram, Timothy A. Yap, Maria Schwaederlé, Richard D. Baird and Ganesh Moorthy. Their work appears in journals such as Cancer Research, Clinical Cancer Research and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026